Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Terminated 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 3Solid Tumors 1Rectal Neoplasms 1Prostatic Neoplasms 1Lymphoma, Follicular 1Gastrointestinal Neoplasms 1Emotional Regulation 1Disease 1Cachexia 1Advanced Solid Tumors 1Advanced Non-small Cell Lung Cancer 1

Interventions

Megestrol Acetate 9Exercise 6Standard of Care 4Blood Specimen Collection 4Olanzapine 3Ibuprofen 3dermcidin 2anamorelin 2Resistance Training 2Physical Therapy Modalities 2Nutrition Assessment 2Mirtazapine 2Melatonin 2Infliximab 2Enteral Nutrition 2Dietary Supplements 2Diet Therapy 2Cyproheptadine 2testosterone enanthate 1telotristat ethyl 1remune 1ostarine 1olanzapine-fluoxetine combination 1nabiximols 1nabilone 1irinotecan sucrosofate 1fucoidan 1clazakizumab 1bermekimab 1alkaloid GB18 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Cachexia × Food × Clear all
NCT00851448 2011-06-02

Safety, Tolerance and Efficacy of an Oral Nutritional Supplement in Lung Cancer Patients

Fresenius Kabi

Phase NA Terminated
17 enrolled

Cachexia, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡